AskTheDate.com
Back to calendar

Spero Therapeutics, Inc. (SPRO) Earnings

SPRO reports earnings on Wednesday, August 12, 2026

earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.17
Actual EPS: $-0.13
EPS surprise: 27.78%
Company overview
Market Cap$98.4M
PriceUSD 1.70
P/E6.98
EPS (TTM)0.24
52-week high3.08
52-week low1.67
SectorHealth Technology
IndustryBiotechnology
Employees25